Agilent Technologies, Inc.
Head Quarters
5301 Stevens Creek Boulevard USWebsite
http://www.agilent.comIndustry
BiotechnologyEmployees
12500Exchange
New York Stock Exchange, Inc.Agilent Technologies, Inc. engages in the provision of core bio-analytical and electronic measurement solutions to the life sciences, chemical analysis, communications and electronics, diagnostics and genomics industries. It operates through the following segments: Life Sciences; Chemical Analysis; Diagnostics and Genomics; and Electronic Measurement. The Life Sciences segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Chemical Analysis segment manufactures gas chromatography mass spectrometry systems, inductively coupled plasma mass spectrometry instruments, atomic absorption instruments, inductively coupled plasma optical emission spectrometry instruments, molecular spectroscopy instruments, vacuum pumps and measurement technologies supports and services. The Diagnostics and Genomics segment provides so
Key statistics
Margins | Stock |
---|---|
Revenue per Employee | $0.00 |
Current Ratio | 3 |
Gross Margin (%) | 0.53% |
Net Margin (%) | 0.04% |
Returns | Stock |
Sales | $4.24B |
Sales Growth (% qtr vs. yr ago) | 0.00% |
Net Income | $116.00M |
NI Growth (% qtr vs. yr ago) | 0.00% |
Price/Sales | 38.59 |
EPS | $1.00 |